Cancer as a Chronic Disease: The Past, the Present and the Future of Cancer Research

TORONTO, ON--(Marketwired - July 18, 2017) - There are over 20 million cancer survivors alive in the world today. Most of these people have been treated for earlier stage cancers with various combinations of therapies, including surgery, radiation and chemotherapy, and most of them will never experience a recurrence of their disease.

A growing number of cancer survivors are living with advanced or metastatic cancers. These patients are unlikely, or unable by current therapies, to be cured of their disease. Yet, like diabetes or chronic renal disease, they increasingly have a chronic condition that can be well managed for prolonged periods of time.

Dr. Schwartzberg will touch on three fundamental points in the treatment and research of cancer as a chronic disease:

• The traditional models of care and research
• Clinical research of cancer as a chronic disease
• Oncology research in emerging markets

By focussing on emerging markets, Dr. Schwartzberg will draw on his research experience in the USA and compare it to the research opportunities he's identified in the Asia-Pacific region. In this emerging market, cancer rates are increasing, largely as a result of the growing middle class, the control of other causes of early mortality such as infection, and adoption of a western lifestyle.

Dr. Schwartzberg will highlight how currently, Australia, for example, has a very high rate/population of cancer incidence when compared to Western Europe and North America. China and Southeast Asia have moderate incidences, roughly half of that of Australia, but in light of the large population, the absolute number of cancer patients is tremendous at approximately three million cases and 2.2 million deaths per year. India has one million cases and 700,000 deaths per year.

With cancer research drawing greater value from their treatment of cancer as a chronic disease and increasing instances of cancer in emerging markets such as the Asia-Pacific, this webinar is not to be missed and would be informative for sponsors interested in discovering the latest advances in cancer research in both traditional and emerging markets.

Dr. Schwartzberg will discuss:

• The emergence of cancer as a chronic disease
• How cancer as a chronic disease impacts the future of oncology trials
• Cancer in emerging markets
• The role of scientific leadership in cancer trials

Join the live broadcast on Tuesday, August 8, 2017 at 1pm EDT. To learn more or register visit: Cancer as a Chronic Disease: The Past, the Present and the Future of Cancer Research

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2017/7/17/11G142816/Images/New_George_Clinical_618x90-ed3ea31fbbb9866bbfbcea9afc17aab1.jpg